The schistosome enzyme that activates oxamniquine has the characteristics of a sulfotransferase
Available evidence suggests that the antischistosomal drug oxamniquine is converted to a reactive ester by a schistosome enzyme that is missing in drug-resistant parasites. This study presents data supporting the idea that the active ester is a sulfate and the activating enzyme is a sulfotransferase...
Main Authors: | Livia Pica-Mattoccia, Daniele Carlini, Alessandra Guidi, Velasco Cimica, Fabio Vigorosi, Donato Cioli |
---|---|
Format: | Article |
Language: | English |
Published: |
Fundação Oswaldo Cruz (FIOCRUZ)
2006-10-01
|
Series: | Memorias do Instituto Oswaldo Cruz |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762006000900048 |
Similar Items
-
Resistance of schistosomes to hycanthone and oxamniquine
by: Donato Cioli, et al.
Published: (1989-01-01) -
Efficacy of oxamniquine, praziquantel and a combination of both drugs in schistosomiasis mansoni in Brazil
by: K. Zwingenberger, et al.
Published: (1987-10-01) -
Evaluation of the schistosomicidal efficacy of liposome - Entrapped Oxamniquine
by: Frédéric Frézard, et al.
Published: (1997-03-01) -
Study of Schistosoma mansoni isolates from patients with failure of treatment with oxamniquine
by: Maria José Conceição, et al.
Published: (2000-06-01) -
Altered Response of Strain of Schistosoma mansoni to Oxamniquine and Praziquantel
by: Patrícia Ivana Pires Bonesso-Sabadini, et al.
Published: (2002-04-01)